# Immunoadsorption in Autoimmune Long COVID

> **NCT07316127** · PHASE2 · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 70 (estimated)

## Conditions studied

- Long COVID
- Long COVID Syndrome
- Long COVID-19 Syndrome
- Post COVID Syndrome

## Interventions

- **DEVICE:** Immunoadsorption
- **DEVICE:** Sham Comparator

## Key facts

- **NCT ID:** NCT07316127
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-12-12
- **Final completion:** 2028-03-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07316127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07316127, "Immunoadsorption in Autoimmune Long COVID". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07316127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*